Matches in Nanopublications for { ?s ?p "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP968315.RAxguA9QiX-3QvwqLvB4o-tgTjOu4PqwHAYqGbdH-Br9c130_assertion description "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968315.RAxguA9QiX-3QvwqLvB4o-tgTjOu4PqwHAYqGbdH-Br9c130_provenance.
- assertion description "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP968324.RAJGxOZObEgzQAAQXbMRSXe_goSFNYuP9ye7BK18xWbTM130_assertion description "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP968324.RAJGxOZObEgzQAAQXbMRSXe_goSFNYuP9ye7BK18xWbTM130_provenance.
- NP353173.RAL-mhb66jk228iEU1GleMICOGGbjlrQuYxJNrjEUIt44130_assertion description "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353173.RAL-mhb66jk228iEU1GleMICOGGbjlrQuYxJNrjEUIt44130_provenance.
- NP353169.RAtbox3m6N65LmzQWbYr4LMDLy0UA0iSLil9Lw1UQt_OI130_assertion description "[In addition, we observed that OVCA2 protein is proteolytically degraded in response to RA and 4HPR treatment in a time- and dose-dependent manner in the promyelocytic leukemia cell line HL60.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP353169.RAtbox3m6N65LmzQWbYr4LMDLy0UA0iSLil9Lw1UQt_OI130_provenance.